Pepsi Bottling Doesn't Wobble

Recs

1

Pepsi Bottling Group (NYSE: PBG) bills itself as the world's largest bottler for PepsiCo (NYSE: PEP). As impressive as that sounds, manufacturing, selling, and distributing beverages isn't that sexy. It's very capital intensive, and Pepsi Bottling is tied primarily to the stale growth in North America. Despite all that, the firm has proven itself a steady grower, and first-quarter results kept it on target for the year.

Total sales advanced 7.5% to $2.7 billion, which is just about the same rate Pepsi Bottling has grown the top line over the past three years. High single-digit expansion is certainly nothing to brag about, but I found it somewhat impressive given that Pepsi just reported negative volumes in its Americas segment, which was mostly because of tougher trends here in the U.S. The majority of Pepsi Bottling's sales stemmed from the U.S. and Canada, accounting for 83% of total revenue, where it saw a 5% increase in quarterly sales and a modest 2% bump in volumes for the quarter. Sales and case increases were led by robust growth in Europe and Mexico, which each make up about 17% of total sales.

Overall operating income fell 10% on charges from a Russian joint venture and a surprise hit from foreign exchange. Raw material costs also increased, but "significant cost productivity gains" helped Pepsi Bottling post flat earnings of $0.12 per share.

If the company hits the high end of its full-year guidance of $2.38, earnings will grow about 8%. That's still not too shabby given the challenging American trends that Pepsi, archrival Coca-Cola (NYSE: KO), and Cadbury Schweppes' (NYSE: CSG) Dr. Pepper and 7-Up brands are seeing.

Similar to my Foolish colleague Matthew Reilly's take on rival Coke's relationship with Coca-Cola Enterprises (NYSE: CCE), I can't see going with Pepsi Bottling over Pepsi itself. Pepsi owns a 35% stake in the bottling group and all of its class B shares. Going with Pepsi gets you plenty of exposure to its most important domestic bottler, plus the more appealing profitability that goes with keeping the lower margin business of bottling operations off the books and the ability to focus more purely on faster-growing global markets.

Related Foolishness:

“Make Big Money With Options” Motley Fool CFO Ollen Douglass recently made over $100,000 buying options on 7 well known stocks. Now we’re committed to turning his small fortune into a massive one! And we want you to join us! Enter your email address to hear more:

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 630593, ~/Articles/ArticleHandler.aspx, 12/1/2009 11:27:38 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
The Public Health-Care Plan's Problem

Related Tickers

12/1/2009 11:08 AM
CBY $53.38 Up +0.01 +0.02%
Cadbury plc CAPS Rating: ***
CCE $19.79 Up +0.14 +0.71%
Coca-Cola Enterpri… CAPS Rating: **
KO $57.82 Up +0.62 +1.08%
The Coca-Cola Comp… CAPS Rating: ****
PBG $38.20 Up +0.25 +0.66%
The Pepsi Bottling… CAPS Rating: ***
PEP $63.27 Up +1.05 +1.69%
PepsiCo, Inc. CAPS Rating: *****

Community: Investing Wiki

Term Of The Hour

PDUFA: The Prescription Drug User Fee Act (PDUFA) is a law enacted by Congress that gives powers to the FDA.

Want to learn more or edit this definition?
Click here to read more!